CSGALNACT2 restricts ovarian cancer migration and invasion by modulating MAPK/ERK pathway through DUSP1.
Cell Oncol (Dordr)
; 2023 Dec 12.
Article
in En
| MEDLINE
| ID: mdl-38082211
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cell Oncol (Dordr)
Year:
2023
Type:
Article
Affiliation country:
China